1. Home
  2. PTGX vs BOWL Comparison

PTGX vs BOWL Comparison

Compare PTGX & BOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • BOWL
  • Stock Information
  • Founded
  • PTGX 2006
  • BOWL 1900
  • Country
  • PTGX United States
  • BOWL United States
  • Employees
  • PTGX N/A
  • BOWL N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • BOWL Services-Misc. Amusement & Recreation
  • Sector
  • PTGX Health Care
  • BOWL Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • BOWL Nasdaq
  • Market Cap
  • PTGX 2.8B
  • BOWL 1.6B
  • IPO Year
  • PTGX 2016
  • BOWL N/A
  • Fundamental
  • Price
  • PTGX $47.91
  • BOWL $10.82
  • Analyst Decision
  • PTGX Strong Buy
  • BOWL Strong Buy
  • Analyst Count
  • PTGX 7
  • BOWL 9
  • Target Price
  • PTGX $52.83
  • BOWL $16.00
  • AVG Volume (30 Days)
  • PTGX 450.1K
  • BOWL 366.9K
  • Earning Date
  • PTGX 11-08-2024
  • BOWL 11-04-2024
  • Dividend Yield
  • PTGX N/A
  • BOWL 1.91%
  • EPS Growth
  • PTGX N/A
  • BOWL N/A
  • EPS
  • PTGX 2.75
  • BOWL N/A
  • Revenue
  • PTGX $319,120,000.00
  • BOWL $1,154,614,000.00
  • Revenue This Year
  • PTGX $400.33
  • BOWL $9.73
  • Revenue Next Year
  • PTGX N/A
  • BOWL $7.42
  • P/E Ratio
  • PTGX $17.54
  • BOWL N/A
  • Revenue Growth
  • PTGX 125.73
  • BOWL 9.05
  • 52 Week Low
  • PTGX $13.76
  • BOWL $8.85
  • 52 Week High
  • PTGX $48.89
  • BOWL $15.47
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 60.40
  • BOWL 42.52
  • Support Level
  • PTGX $45.33
  • BOWL $11.15
  • Resistance Level
  • PTGX $48.89
  • BOWL $11.79
  • Average True Range (ATR)
  • PTGX 1.28
  • BOWL 0.43
  • MACD
  • PTGX 0.11
  • BOWL -0.09
  • Stochastic Oscillator
  • PTGX 77.11
  • BOWL 3.99

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About BOWL Bowlero Corp.

Bowlero Corp is a operator of bowling entertainment centers. It operate traditional bowling centers and more upscale entertainment concepts with lounge seating, arcades, enhanced food and beverage offerings, and more robust customer service for individuals and group events, as well as hosting and overseeing professional and non-professional bowling tournaments and related broadcasting.

Share on Social Networks: